Diabetic Wounds Market Report 2026

Diabetic Wounds Market Overview

• Diabetic Wounds market size has reached to $2.33 billion in 2025 • Expected to grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Rising Obesity Rates Fuels Growth In The Diabetic Wounds Market • Market Trend: Next-Generation Therapeutic Devices Improve Comfort And Support Faster Healing • North America was the largest region in 2025.

What Is Covered Under Diabetic Wounds Market?

Diabetic wounds are slow-healing wounds that commonly occur in individuals with diabetes. These wounds result from a combination of factors, including neuropathy, poor circulation, and high blood sugar levels, leading to disordered healing processes and an increased risk of infection and complications. The product types for diabetic wounds are wound care dressings, wound care devices, skin grafts and substitutes, growth factors, and others. Wound care dressings are specialized materials applied directly to diabetic wounds to protect them from contamination and promote healing. The various wound types include neuropathic ulcer wounds, ischemic ulcer wounds, and neuro-ischemic ulcer wounds for different end-users, such as hospitals, specialty clinics, and others.

What Is The Diabetic Wounds Market Growth Forecast?

The diabetic wounds market size is expected to see strong growth in the next few years. It will grow to $3.26 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growth in regenerative medicine, expansion of homecare services, innovation in wound dressings, increasing outpatient care adoption, focus on reducing complications. Major trends in the forecast period include increasing use of advanced wound care products, growing adoption of biologic and regenerative therapies, rising demand for home-based wound management, expansion of chronic wound care centers, increased focus on infection prevention.

What Is The Driver Of The Diabetic Wounds Market?

An increase in obesity cases is expected to propel the growth of the diabetic wounds market going forward. Obesity is a health condition where too much body fat is stored, potentially harming one's health. Obesity is becoming more common mainly because people are leading more sedentary lives, spending more time sitting and less time being physically active. Obesity is linked to diabetic wounds because extra body fat can cause insulin resistance, which hinders blood sugar control and slows wound healing. For instance, in September 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, 23 states reported adult obesity prevalence of 35% or higher in 2023, and all 50 states recorded obesity rates of at least 20%. Therefore, the increase in obesity cases is driving the growth of the diabetic wound industry.

Key Players In The Global Diabetic Wounds Market

Major companies operating in the diabetic wounds market are 3M Health Care, Medline Industries Inc., B. Braun Melsungen AG, Smith & Nephew plc, Coloplast A/S, Hartmann Group, ConvaTec Group Plc, Mölnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Hollister Incorporated, Organogenesis Inc., MiMedx Group Inc., LifeNet Health, Derma Sciences Inc., Kerecis, DermaRite Industries LLC, MediWound Ltd., Tissue Regenix Group plc, Systagenix Wound Management, XenoTherapeutics, Alliqua BioMedical Inc.

Global Diabetic Wounds Market Trends and Insights

Major companies operating in the diabetic wounds market are focusing on developing advanced solutions, such as portable negative pressure wound therapy (NPWT) systems, to support more effective, convenient, and patient-centered management of diabetic foot ulcers and other chronic wounds. Portable NPWT systems apply controlled suction to the wound through a compact pump and sealed dressing, helping remove exudate, reduce swelling, improve circulation, and accelerate tissue regeneration offering a more active and therapeutic alternative to traditional wound dressings. For instance, in April 2024, Smith+Nephew, a UK-based medical technology company, introduced the RENASYS EDGE NPWT System, a next-generation, home-use device designed for simplicity and comfort. The system features a lightweight and quiet design, a discreet 300 mL canister, guided setup animations via an intuitive interface, over 24 hours of battery life, and built-in self-test functionality to minimize maintenance. These advancements make the system easier for patients to wear and operate, enabling seamless integration of wound therapy into daily life.

What Are Latest Mergers And Acquisitions In The Diabetic Wounds Market?

In May 2023, LifeNet Health, a US-based regenerative medicine solutions company, acquired the wound care division of Bioventus Inc. for $85 million. Through this acquisition, LifeNet Health aims to enhance its wound care solutions by adding Bioventus Inc.’s product, TheraSkin, and position itself as a more robust global leader in regenerative medicine. Bioventus Inc. is a US-based biotechnology company specializing in advanced wound care, such as Theraskin, which improves the healing process in diabetic foot ulcers.

What Defines the Diabetic Wounds Market?

The diabetic wounds market consists of sales of antibacterial creams, gels, negative pressure wound therapy (NPWT) systems, and wound cleansers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diabetic Wounds Market Report 2026?

The diabetic wounds market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic wounds industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.